UPC APP 27426/2025

—·EP2726883: A CELL MEDIATED IMMUNE RESPONSE ASSAY WITH ENHANCED SENSITIVITY

Verfahrensdetails: Status
—
Verfahrensart
Verfahrensantrag
Kategorie
Akteneinsicht (RoP262)
Parteien: Kläger
QIAGEN Sciences, LLC
Vertreter: Clemens Plassmann (Hogan Lovells International LLP); Markus Kuczera (Hogan Lovells International LLP)
Beklagte
bioMérieux SA
bioMérieux Deutschland GmbH
Vertreter: Oliver Jan Jüngst (Bird & Bird LLP); Annika L. Lückemann (Bird & Bird LLP)
Division: Dusseldorf LD
Richter: Jule Schumacher · Judge-rapporteur
Technology: Measurement & Testing
Sprache: —
Erste Entscheidung: 15. Juli 2025

Entscheidungen

2025-07-15
Application RoP262A
The Düsseldorf Local Division issued a procedural order granting confidentiality protection under Rule 262A RoP for information contained in the defendants' statement of defence (peptide compositions and related analyses) in an infringement action by QIAGEN Sciences against bioMérieux concerning EP 2 726 883.
Rechtsfragen:Confidentiality protection under Rule 262A RoPScope of confidentiality order in infringement proceedings

Dokumente